Use of an anti-A and anti-B antibody-depleted immunoglobulin G (IgG) concentrates for the treatment of jaundice in infants by incompatibility of the AB0 system between the parent and child
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
发明人:
ELZAABI, MAZEN
申请号：
DK09803869
公开号：
DK2358391T3
申请日:
2009.12.16
申请国别(地区):
DK
年份:
2015
代理人:
摘要：
An embodiment relates to the use of an immonuglobulin (IgG) concentrate depleted of anti-A (AcaA) and anti-B (AcaB) antibodies for producing a drug intended for treating neonatal jaundice caused by maternal-fetal incompatibility with respect to the ABO system.
